Role for Retinoic Acid-Related Orphan Receptor Alpha (RORα) Expressing Macrophages in Diet-Induced Obesity by Harns, Emily et al.
ORIGINAL RESEARCH
published: 27 August 2020
doi: 10.3389/fimmu.2020.01966
















This article was submitted to
Inflammation,
a section of the journal
Frontiers in Immunology
Received: 22 April 2020
Accepted: 21 July 2020
Published: 27 August 2020
Citation:
Hams E, Roberts J, Bermingham R,
Hogan AE, O’Shea D, O’Neill L and
Fallon PG (2020) Role for Retinoic
Acid-Related Orphan Receptor Alpha




Role for Retinoic Acid-Related
Orphan Receptor Alpha (RORα)
Expressing Macrophages in
Diet-Induced Obesity
Emily Hams 1, Joseph Roberts 1, Rachel Bermingham 1, Andrew E. Hogan 2, Donal O’Shea 3,
Luke O’Neill 4 and Padraic G. Fallon 1*
1 School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland, 2Department of Biology,
National University of Ireland, Maynooth, Ireland, 3Obesity Immunology Research, St. Vincent’s University Hospital and
University College Dublin, Dublin, Ireland, 4 School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute,
Trinity College Dublin, Dublin, Ireland
The transcription factor RORα plays an important role in regulating circadian rhythm,
inflammation, metabolism, and cellular development. Herein we show a role for
RORα-expressing macrophages in the adipose tissue in altering the metabolic state
of mice on a high-fat diet. The expression of Rora and RORA is elevated in white
adipose tissue from obese mice and humans when compared to lean counterparts.
When fed a high-fat diet Rora reporter mice revealed increased expression of Rora-YFP
in macrophages in white adipose tissue deposits. To further define the potential role
for Rora-expressing macrophages in the generation of an aberrant metabolic state
Rorafl/flLysMCre/+ mice, which do not express Rora in myeloid cells, were maintained
on a high-fat diet, and metabolic parameters assessed. These mice had significantly
impaired weight gain and improved metabolic parameters in comparison to Rorafl/fl
control mice. Further analysis of the immune cell populations within white adipose tissue
deposits demonstrates a decrease in inflammatory adipose tissue macrophages (ATM).
In obese reporter mouse there was increased in Rora-YFP expressing ATM in adipose
tissue. Analysis of peritoneal macrophage populations demonstrates that within the
peritoneal cavity Rora-expression is limited to myeloid-derived macrophages, suggesting
a novel role for RORα in macrophage development and activation, which can impact on
metabolism, and inflammation.
Keywords: RORα, macrophage, inflammation, metabolism, obesity
INTRODUCTION
The transcription factor retinoic acid receptor-related orphan receptor alpha (RORα) is a member
of the nuclear hormone receptor superfamily, which provides a bridge between hormonal,
nutritional, and pathophysiological signaling and gene regulation. RORα itself has been identified
as having roles in neural development, metabolism, cellular differentiation, immune regulation, and
circadian rhythm. Indeed, staggerer mice (Rorasg/sg), which express a truncated form of the RORα
protein due to a spontaneous mutation in the Rora gene, show aberrant immune responses (1–4).
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Studies on RORα in the context of immunity have
focused primarily on two aspects; regulation of immune
signaling pathways, and involvement in immune cell
development. Expression of RORα is induced in tissue and
cells, including macrophages, in response to inflammatory
stimuli, suggesting a role in the immune response (5, 6).
Indeed, RORα has been implicated in the inflammatory
response to the TLR agonist lipopolysaccharide (LPS)
through its ability to down-modulate NF-κB signaling
and impair activation of the NLRP3 inflammasome
(1, 2, 5).
RORα has also been linked with allergic and autoimmune
diseases, with RORA implicated in the development of asthma
(7) and also increased susceptibility to multiple sclerosis
(8). Similarly, in experimental models Rorasg/sg mice show
attenuated allergic inflammatory responses in allergen-induced
lung inflammation (9); while mice deficient in RORα and
RORγ are completely refractory to the development of
experimental autoimmune encephalomyelitis (10). Furthermore,
in the skin RORα-expressing T regulatory cells are involved
in allergic inflammation (11). In addition to the inhibition
of inflammatory signaling pathways, RORα has also been
identified as critical in the development of Th17 cells and
group 2 innate lymphoid cells (ILC2), which may explain the
attenuation of allergic and autoimmune conditions seen in these
studies (10, 12).
Within the context of metabolism RORα has an important
role in lipid and glucose metabolism. Rorasg/sg mice, which
are resistant to diet-induced obesity, show increased insulin
sensitivity with increase adipocyte lipid storage capacity without
harboring hyperlipidemia or hepatic steatosis. This increase in
energy storage in Rorasg/sg mice is believed to be mitigated
in part through increased “browning” of white adipose tissue
(WAT) in these mice. During this process, increased energy
expenditure occurs as a result of heat generation associated
with increased expression of uncoupling protein 1 (UCP1). In
Rorasg/sg mice there is increased UCP1 in both inguinal BAT
and WAT (13).
In this study, we demonstrate a role for the Rora expressing
macrophages in obesity. Rora-YFP reporter mouse were
used in a diet-induced model of obesity to identify Rora
expressing cells within the adipose tissue. The primary cell
populations expressing Rora-YFP in adipose tissue were
inflammatory adipose tissue macrophages (ATM), with
increased frequency of ATM in obese animals. When fed a
high fat diet Rorafl/flLysMCre/+ mice, which have a myeloid-
cell specific deletion of Rora, developed increased weight
gain with glucose sensitivity compared to control animals.
We further show that deletion of Rora in myeloid cells is
sufficient to impact on genes associated with thermogenesis,
suggesting Rora-expressing macrophages not only impact on
inflammation and obesity, but also regulate metabolic gene
expression within the adipose tissue. This study highlights
the importance of Rora-expressing macrophages in the




C57BL/6J (wild type; WT), Rorasg/sg (JAX Strain: 002651),
R26R-EYFP (JAX Strain: 006148), Lyz2tm1(cre)Ifo (JAX Strain
004781) were purchased from Jackson Laboratories (Bar Harbor,
MD, USA). Conditional Rora floxed mice were generated
(Lexicon Pharmaceuticals, USA) and homozygous mice crossed
to Lyz2tm1(cre)Ifo (referred to herein as LysMCre/+) to generate
animals with a conditional deletion of Rora in cells of a myeloid
lineage, and IL-7RaCre/+ (14) for conditional deletion of Rora in
cells expressing IL-7Rα (Rorafl/flIl7rCre mice). Roratm1(cre)Ddmo
mice (15) were crossed with R26R-EYFP mice to generate Rora-
YFP reporter mice (referred to herein as Rora-YFP). Male mice
were used in all studies. Animals were housed in a specific
pathogen-free facility in individually ventilated and filtered cages
under positive pressure. All animal experiments were performed
in compliance with the Health Product’s Regulatory Authority
and approved by the Trinity College Dublin’s BioResources
ethical review board.
It is relevant that due to the importance of RORα in regulating
circadian rhythm (16), and the corresponding circadian rhythm
known to govern circulating monocytes and thus potentially
impacting upon the inflammatory response (17), all experiments
on mice and tissue isolations were performed at 10–12 a.m. to
ensure no variations occurred due to alterations in the circadian
rhythm due to time differences in experiments.
Human Adipose Tissue Samples
RNA was isolated from snap-frozen omental adipose tissue
biopsies from obese patients (body mass index, BMI <
50) undergoing elective bariatric surgery and from control
patients with a healthy BMI (18–23) undergoing elective
abdominal surgery. Clinical studies were approved by the
St. Vincent’s University Hospital, Dublin, Ethics committee.
Written informed consent was obtained from each patient before
commencement of research activities.
High Fat Diet and in vivo Metabolic Testing
A mouse model of diet-induced obesity by feeding high fat diet
(HFD) was as described (24, 25). Age-matched male Rorafl/fl and
Rorafl/flLysMCre/+ mice were fed a HFD (60% kcal fat; D12492;
Research Diets, Inc., NJ, USA) or control diet (10% kcal fat;
D12450J) ad libitum for 16 weeks. Male mice were used for all
HFD studies due to the published differences in the development
of metabolic syndrome between males and females, with male
mice on a C57BL/6 mice showing a higher predisposition to
weight gain and metabolic dysfunction than female counterparts
(18, 19). Glucose tolerance was assessed in mice fasted overnight
and challenged with 2 g/kg glucose i.p. Insulin tolerance was
tested in mice fasted for 4 h and challenged with 0.75 mU/g
human insulin i.p. Blood glucose was measured prior to injection
and at 30, 60, and 120min post-injection using a glucometer
(Abbott Laboratories, IL, USA). All metabolic analyses were
undertaken between 10.00 and 12.00, all weight measurements
were taken at 10.00.
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Serum Transaminase Assay
Free triglycerides and alanine transaminase (ALT) and
aspartate transaminase (AST) were measured in the serum
of Rorafl/fl and Rorafl/flLysMCre/+ mice after 16 weeks on HFD.
Serum was assessed for triglyceride levels using the Abnova
triglyceride quantification kit (Heidelberg, Germany) following
the manufacturer’s instructions. ALT and AST activity was
determined in the serum using commercial kits from Abcam
(Cambridge, UK) following the manufacturer’s instructions.
In vivo Antibody Treatment
Groups of age-matched male RoraCreRosaYFPmice were treated,
using a method previously described (20), with IL-4/anti-IL-4
monoclonal antibody (mAb) complexes (IL-4c), thioglycollate
(4% w/v; Sigma, Wicklow, Ireland), or thioglycollate + IL-4c i.p.
IL-4c was prepared by incubating 5 µg recombinant mouse IL-
4 (Peprotech, London, UK) with 25 µg anti-lL-4 mAb (clone
11B11, BioXcell, NH, USA). Briefly mice were injected with
PBS or IL-4c i.p. on days 0 and 2. Mice were also treated
with thioglycollate (day 0) or thioglycollate (day 0) plus IL-4c
(day 0 and 2). Peritoneal cells were collected from all mice on
day 4 by lavaging the peritoneal cavity with ice-cold PBS for
flow cytometry.
Adipose Tissue Stromal Vascular Cell
Isolation
The stromal vascular fraction was isolated from adipose tissue
and prepared for flow cytometry or culture. Briefly, the adipose
tissue deposits (epididymal and inguinal white adipose tissue; E-
WAT and I-WAT, respectively) were removed, weighed, minced
and digested with 1 mg/ml Collagenase D from Clostridium
histolyticum (Roche, Dublin, Ireland) for 30min at 37◦C for
30min with shaking. Digested tissue was passed through a 70µM
cell strainer and cells pelleted at 1,500 rpm for 5min. Red blood
cell contamination was removed by incubation with a hypotonic
lysis solution. Cells were used for flow cytometry or cultured for
2 h in RPMI-1640 supplemented with 2mM L-glutamine, 100
U/ml penicillin and 100µg/ml streptomycin at a density of 2 ×
106 cells/ml at 37◦C with 5% CO2. Gene expression was assessed
in adherent cells.
Murine Macrophage Isolation and Culture
Peritoneal macrophages were cultured from naive C57BL/6J,
Rorasg/sg and RoraCreRosa-YFP mice as previously described
(21). Briefly, the peritoneal cavity was lavaged with 5ml ice-cold
PBS and the resulting cells plated at 2 × 106 cells/ml in RPMI-
1640 supplemented with 2mM L-glutamine, 100 U/ml penicillin
and 100µg/ml streptomycin and incubated for 2 h at 37◦C with
5% CO2, and any non-adherent cells removed. Adherent cells
were collected for gene expression analysis.
Bone marrow derived macrophages (BMDM) were cultured
from the tibia and fibula of mice as previously described
(21). Briefly, cells were flushed from the tibia and fibula to
prepare a single cell suspension. After red blood cell lysis,
the resultant cells were cultured at 3 x 106 cells/ml in
RPMI-1640 supplemented with 2mM L-glutamine, 100 U/ml
penicillin, 100µg/ml streptomycin and 10% fetal calf serum,
with 20% L929 supernatant at 37◦C with 5% CO2 for 7 days.
BMDM were collected for gene expression analysis after 7 days
culture. Separately, BMDM were stimulated with IL-4 (20 ng/ml;
Peprotech, London, UK) or ultra-pure LPS (100 ng/ml; from
Escherichia coli 0111:B4 strain, InvivoGen, France) for 48 h and
cells collected for flow cytometry.
Flow Cytometry
Surface marker expression was assessed by flow cytometry
with data collection on a CyAn ADP (Beckman Coulter, High
Wycombe, UK) and data analyzed using FlowJo software (Tree
Star, OR, USA). Cells, isolated as previously described, were
stained with BD Biosciences (Oxford, UK) mAbs; Siglec-F-PE
(E50-2440), CD45.2-PE-CF594 (104), CD11b-APCCy7 (M1/70);
eBioscience (Loughborough, UK) mAb; MHC class II-eFluor
450 (MS/114.15.2); and BioLegend (London, UK) mAbs; F4/80-
FITC (BM8), Ly6C-PerCP (HK1.4), CD64-APC (X54-5/7.1),
CD9-PECy7 (MZ3), CD206-PECy7 (C068C2), and CD115-PE
(CSF-1R). Prior to surface staining, cells were incubated with
LIVE/DEAD Fixable Aqua stain (Molecular Probes, Invitrogen,
Dublin, Ireland) to isolate dead cells. Using appropriate controls,
quadrants were drawn and data were plotted on logarithmic
scale density-plots.
RNA Isolation and Real-Time PCR
RNA was isolated from cultured cells and snap frozen adipose
tissue deposits. For all cultured cells, RNA was isolated using
the RNeasy kit (Qiagen, Hilden, Germany); RNA was isolated
from adipose tissue samples using phenol/chloroform extraction.
Briefly ∼50mg tissue was homogenized in 500 µl TRIzol R©
(ThermoFisher, Loughborough, UK), incubated on ice for 5min
and cellular debris removed by centrifugation. Chloroform (1:5
v/v) was added to the TRIzol suspension, mixed by vortex
and incubated for 3min, then separated by centrifugation.
The aqueous layer was collected and RNA precipitated using
1:1 (v/v) isopropanol. RNA was pelleted by centrifugation
and reconstituted in DEPC treated H2O. Resultant RNA was
reverse transcribed using the Quantitect reverse transcription
kit incorporating a genomic DNA elimination step (Qiagen,
Hilden, Germany).
Real-time quantitative PCR was performed on an Applied
Biosystems StepOne Plus sequence detection system (Applied
Biosystems, Dublin, Ireland) using pre-designed TaqMan gene
expression assays specific for murine Rora (Mm00443103_m1),
Nos2 (Mm00440485_m1), Arg1 (Mm00475988_m1),
Ccl2 (Mm00441242_m1), Tnf (Mm00443258_m1), Chil3
(Mm00657889_mH), Ucp1 (Mm01244861_m1), Elovl3
(Mm00468164_m1), Cidea (Mm00432554_m1), Cpt1b
(Mm00487191_g1), Ppargc1 (Mm01208835_m1), and human
RORA (Hs00536545_m1) and normalized to 18S.
Statistics
Statistical analysis was performed using GraphPad 8. Results are
presented as mean ± SEM. Statistical difference between groups
were analyzed by unpaired Student’s t-test withWelch correction
or ANOVA and Tukey’s multiple comparison test. P-values were
considered significant when P > 0.05.
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FIGURE 1 | Rora expression is increased in myeloid cells in adipose tissue isolated from obese subjects. Expression of the gene encoding RORα was determined in
mice (Rora) and human (RORA) (A,B, respectively). RNA was isolated from the E-WAT isolated from both lean and obese humans and mice, gene expression was
(Continued)
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FIGURE 1 | quantified by qPCR and normalized based on 18S expression (n = 3 lean mice, n = 7 obese mice; n = 6 lean or obese patients). RoraCre and
RoraCreRosa-YFP mice were fed a high-fat diet for 12 weeks and flow cytometry performed on epididymal and inguinal white adipose tissue (E-WAT and I-WAT,
respectively). Cells were gated as Live/dead−CD45+ and assessed for Rora-YFP expression (C, data is representative of 3 RoraCre and 7 RoraCreRosa-YFP mice). (D)
Rorafl/fl and Rorafl/flLysMCre/+ mice were fed a high-fat diet for 16 weeks and RNA isolated from E-WAT and I-WAT; expression of Rora was assessed relative to 18S (n
= 6). Data is representative of mean ± SEM. Student’s t-test: *P < 0.05, ***P < 0.001.
RESULTS
Rora Expression Is Increased in Adipose
Tissue Macrophages in Obesity
RORα has previously been associated with metabolic
dysfunction, with key roles in lipid and glucose metabolism.
Indeed, RORα-deficient staggerer mice are protected against
age- and diet-induced obesity, hepatosteatosis and insulin
resistance (3). The decreased adiposity in these mice is associated
with decreased triglyceride deposition and reduced expression
of a number of genes associated with lipid metabolism,
including apolipoprotein A-1 (apoA1) and apolipoprotein C-
III (apoCIII) (22, 23). Further analysis using a liver-specific
conditional deletion of Rora (RORαLKO) demonstrated
an increase in proliferators-activated receptor-γ (PPARγ),
which resulted in impaired negative self-regulation thus
protecting against hepatosteatosis (26). These studies clearly
demonstrate a role for RORα in regulating the processes
that underlie obesity. Indeed, we see increased expression
of Rora/RORA gene expression in white adipose tissue
isolated from obese subjects, both mouse and humans,
respectively, when compared to their lean counterparts
(Figures 1A,B).
Obesity is considered an inflammatory condition, mediated
by the inflammatory cell milieu in the adipose tissue and
heavily influenced by the ATM, with inflammatory macrophages
associated with an obese state (27). To determine the cellular
location of RORα we generated a Rora reporter mouse, by
interbreeding a RoraCre mouse with R26R-YFP to generate a
strain co-expressing Rora and YFP, enabling Rora expression
to be visualized as YFP by flow cytometry. We confirmed
detected YFP+ve cells express Rora by sorting YFP+ve and
YFP−ve CD45+ve populations from naïve splenocytes and
assessing Rora gene expression in the sorted populations by RT-
PCR (Supplementary Figures 1A,B). We fed male 8 week-old
RoraCre/+ control and Rora-YFP mice a high-fat diet for 16
weeks and isolated the E-WAT and I-WAT for flow cytometry.
In AT of obese mice CD11b+ cells were the dominant Rora-
YFP expressing CD45-expressing cell population, with CD4+
T cells and type 2 innate lymphoid cells (ILC2), cell subsets
associated with high expression of RORα, representing just
2 and 0.6% of Rora-expressing cells, respectively, in obese
AT, CD45−ve cells in the E-WAT did not express Rora-
YFP (Figure 1C, Supplementary Figures 2A,B). Indeed, ILC2s
are widely associated with a lean phenotype and decrease in
number in obese adipose tissue, which suggests that RORα
may play differential roles in regulating metabolic disease
dependent upon the cell type in which it is expressed
(24, 25). Interestingly expression was higher in the inguinal
adipose tissue, supporting differential effects of RORα in E-
WAT and I-WAT in the context of thermogenesis (13).
Confirming the expression of Rora in adipose tissue myeloid
cells, we show decreased Rora expression in AT isolated
from Rorafl/flLysMCre/+ mice compared to Rorafl/fl animals
(Figure 1D).
Myeloid Cell Expression of RORα Results
in Exacerbated Metabolic Distress
Myeloid cells, particularly macrophages, play important roles
in maintaining metabolic homeostasis, with the development of
metabolic diseases, such as type 2 diabetes, being linked with the
presence of inflammatory macrophages in the adipose tissue (28).
To assess if this observed increase in Rora expression in myeloid
cells could impact on the generation of obesity and metabolic
homeostasis, adult male Rorafl/fl and Rorafl/flLysMCre/+ mice
were maintained on a HFD for 16 weeks. Rorafl/flLysMCre/+ mice
had significantly (P< 0.05) decreased weight gain throughout the
feeding period compared to Rorafl/fl counterparts (Figure 2A),
which was associated with decreased inguinal adipose tissue
weight (Figure 2B). Again, it is interesting that we specifically
see a marked effect in the inguinal AT, which supports the
previous expression data (Figure 1C). The reduced weight
gain was associated with improved metabolic function, with
significantly increased glucose tolerance (P < 0.001) and insulin
sensitivity (P < 0.01), in the absence of Rora-expressing myeloid
cells (Figure 2C). We saw no alteration in AST/ALT ratio,
which serves as a marker for hepatosteatosis, suggesting that
a myeloid cell deletion of Rora is not sufficient to convey
protection against obesity-related liver damage (Figure 2D). To
demonstrate that the weight loss observed is specifically due
to the deletion of Rora in myeloid cells, and not an off-
target effect of disrupting the Rora gene, Rorafl/flIL-7RaCre/+
mice—a commonly used mouse to model ILC2 deficiency
(29, 30)—were placed on HFD and used as an additional
strain where Rora has been conditionally deleted in a specific
cell type. In marked contrast to the reduced weight gain
in mice with myeloid specific deficiency in Rora, Rorafl/flIL-
7RaCre/+ mice had increased weight gain in response to
HFD (Supplementary Figures 3A,B), reinforcing cell-specific
functions for Rora in obesity.
RORα has been studied extensively for its role in lipid
metabolism. Indeed, deletion of Rora from the liver specifically
results in exacerbated weight gain and insulin resistance
associated with enhanced transcriptional activity of PPARγ
resulting in uncontrolled lipogenesis (26). Furthermore,
expression of genes associated with thermogenesis and fatty
acid oxidation were also altered in these mice (26). However,
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FIGURE 2 | Continued
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FIGURE 2 | Rorafl/flLysMCre/+ mice show decreased weight gain and improved metabolic function associated with increased expression of genes associated with
thermogenesis. Groups of Rorafl/fl and Rorafl/flLysMCre/+ mice were fed a high-fat diet (HFD; 60% fat) for 16 weeks and weight monitored weekly, percentage weight
gain was calculated from the starting weight of each animal and starting and final weight is quantified for each group (A, n = 11 Rorafl/fl; n = 19 Rorafl/flLysMCre/+ ).
E-WAT, I-WAT and S-BAT (subcutaneous brown adipose tissue) weight was determined after 16 weeks on HFD (B, n = 7 Rorafl/fl; n = 6 Rorafl/flLysMCre/+ ). Glucose
and insulin tolerance tests (GTT and ITT, respectively) were performed on mice after 14 and 15 weeks on HFD respectively (C, n = 8 Rorafl/fl; n = 6 Rorafl/flLysMCre/+ ).
The serum AST/ALT ratio was calculated from AST and ALT activity tests on the serum from Rorafl/fl and Rorafl/flLysMCre/+ mice after 16 weeks on HFD (D, n = 8
Rorafl/fl; n = 6 Rorafl/flLysMCre/+ ). E-WAT, I-WAT, and S-BAT were excised after 16 weeks on HFD (n = 6 Rorafl/fl; n = 6 Rorafl/flLysMCre/+ ). RNA was isolated and
expression of genes associated with the metabolic and thermogenic function of the adipose tissue were assessed (E). All data is representative of mean ± SEM.
Student’s t test: *P < 0.05, **P < 0.01, ***P < 0.001.
Rorasg/sg mice, which have a ubiquitous deletion of functional
RORα, show decreased susceptibility to diet-induced obesity
and an increase in thermogenesis associated with increases
in UCP1 (13). We assessed the expression of Ucp1, Elovl3,
Cidea, Cptb1, and Ppargc1, genes associated with thermogenesis,
in both WAT and BAT deposits from obese Rorafl/fl and
Rorafl/flLysMCre/+ mice. There was significant increase in Ucp1
and also Elovl3 in Rorafl/flLysMCre/+ mice, suggesting that
an absence of Rora-expressing myeloid cells is sufficient to
impact on genes driving thermogenesis in the adipose tissue
(Figure 2E).
Altered Macrophage Populations in the
Adipose Tissue of Rorafl/flLysMCre/+ Mice
The immune profile of WAT largely dictates the metabolic status
of the mice, ATM playing a major role. There are multiple
distinct populations of macrophages within the adipose tissue,
which do not fit the archetypal M1/M2 classifications (31).
Recently Ly6C and CD9 expression (Ly6Chi and Ly6CloCD9+
or Ly6CloCD9−) has been used to identify populations of
ATM (31). Ly6Chi macrophages are myeloid-derived adipogenic
cells which reside outside the crown-like structures (CLS) in
the adipose tissue, while Ly6Clo macrophages reside in the
CLSs that can further divided on their expression of CD9,
with CD9+ve cells classified as pro-inflammatory lipid laden
ATM (31). We assessed the ATM populations in obese and
lean Rorafl/fl and Rorafl/flLysMCre/+ mice using Ly6C and
CD9 expression to identify 3 different macrophage subtypes.
While there is increase in Ly6Chi ATM in mice fed a HFD
in both the E-WAT and I-WAT, there were significantly fewer
(P < 0.05 and P < 0.01 in E-WAT and I-WAT, respectively)
Ly6Chi ATM in Rorafl/flLysMCre/+ compared to Rorafl/fl mice
(Figures 3A,C). Analysis of the Ly6Clo population demonstrates
significantly (P < 0.01) decreased accumulation of CD9+ve
ATM in HFD fed Rorafl/flLysMCre/+ compared to Rorafl/fl
mice (Figures 3B,D), suggesting decreased lipid laden, pro-
inflammatory macrophages in the AT in the absence of Rora-
expressing myeloid cells.
Rora-YFP mice were used to investigate RORα expression
in the 3 ATM populations. Rora-YFP cells were present in
both the Ly6Chi and CD9+ ATM populations (Figure 3E).
The Ly6Chi ATM population are myeloid derived and
supports normal adipose tissue function, angiogenesis and
adipogenesis (31), the relatively high expression in these cells
suggests a possible role for RORα maintaining adipose tissue
architecture and function. There was increased expression in
the CD9+ population, supporting a possible role for RORα
in inflammation within the context of the adipose tissue,
which may be linked with its role in metabolic dysregulation.
Furthermore, using archetypal classically activated macrophage
(CD11b+SiglecF−F4/80+CD206lo; CAM) and alternatively
activated macrophage (CD11b+SiglecF−F4/80hiCD206hi; AAM)
phenotyping there were decreased CAM and increased AAM
in Rorafl/flLysMCre/+ compared to Rorafl/fl mice (Figure 3F).
These data confirm the potential for important functional roles
for Rora-expressing macrophages in the adipose tissue.
Decreased Inflammatory Monocytes in the
Blood in the Absence of RORα
While there are populations of resident ATM, the populations we
assessed were myeloid-derived (28, 31). Indeed, the expression
of Ly6C on ATM indicate that they are monocyte-derived
and recently recruited to the adipose tissue (32). With a
large proportion of Ly6Chi ATM expressing Rora, we assessed
blood monocyte populations in the absence of RORα. Using
Ly6C as a marker of inflammatory blood monocytes (17),
there was a significant (P < 0.05) reduction in Ly6Chi
inflammatory blood monocytes in Rorasg/sg mice compared to
WT counterparts (Figure 4A). Once again, it is the Ly6Chi
monocyte population that show a higher percentage of Rora-
YFP expression, compared to Ly6Clo monocytes (Figure 4B),
suggesting that Rora expression is higher in the inflammatory
monocyte population. To confirm the observed decrease in
Ly6Chi blood monocytes is due to Rora expression in myeloid
cells specifically, rather than any downstream effects of a
ubiquitous RORα deletion, we assessed blood monocytes in
Rorafl/flLysMCre/+ mice. We see a comparable significant (P <
0.05) decrease in Ly6Chi monocytes in Rorafl/flLysMCre/+ to
that observed in Rorasg/sg mice (Figure 4C), confirming that the
decrease in this inflammatory monocyte population is due to
Rora expression in the population.
RORα Expression Is Higher in
Myeloid-Derived Macrophages
Data presented thus far has demonstrated that Rora expressed
in macrophages and monocytes are predominately of a myeloid
origin. Indeed, there is decreased Rora gene expression in BMDM
isolated from Rorasg/sg, compared to cells isolated fromWTmice
(Figure 5A). BMDM from Rora-YFP reporter mice had a small
population ofRora-YFP+ve cells, that expanded upon stimulation
with LPS, but not IL-4, suggesting that classical inflammatory
stimuli can drive expression of Rora in these cells (Figure 5B).
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FIGURE 3 | Rorafl/flLysMCre/+ mice show decreased Ly6Chi ATM and fewer CD9+ inflammatory ATM in obese animals. Groups of Rorafl/fl and Rorafl/flLysMCre/+ mice
were fed a control diet (CD; n = 5 Rorafl/fl, n = 3 Rorafl/flLysMCre/+ ) or a high-fat diet (HFD; n = 7 Rorafl/fl, n = 6 Rorafl/flLysMCre/+) for 16 weeks and the E-WAT and
I-WAT isolated and prepared for flow cytometry. Cells isolated from the E-WAT were gated as Live-dead−CD45+SiglecF− and assessed for Ly6C expression (A).
Ly6Clo cells were further assessed for CD64 and CD9 expression (B). This gating strategy was repeated in cells isolated from I-WAT (C,D, n = 2 Rorafl/fl CD, n = 1
Rorafl/flLysMCre/+ CD; n = 7 Rorafl/fl HFD, n = 6 Rorafl/flLysMCre/+ HFD). RoraCre and RoraCreRosa-YFP mice were fed a high-fat diet for 12 weeks and flow cytometry
performed on E-WAT. Cells were gated as Live-dead−CD45+SiglecF−CD11b+ then gated as described previously based on Ly6C expression, then CD9 expression,
as indicated, and assessed for Rora-YFP expression (E, data is representative of 3 RoraCre and 3 RoraCreRosa-YFP mice). (F) Cells isolated from the E-WAT from HFD
fed Rorafl/fl and Rorafl/flLysMCre/+ mice were stained as CAM (CD11b+SiglecF−F4/80+CD206lo) or AAM (CD11b+SiglecF−F4/80hiCD206hi; n = 6–7). Data is
representative of mean ± SEM. Student’s t-test: ns, not significant, *P < 0.05, **P < 0.01.
Studies above focused on myeloid-derived cells, to assess
the potential impact of RORα on tissue resident cells we have
used the peritoneal cavity as a source of macrophages. The
peritoneal cavity has a resident population of macrophages,
which are yolk sac derived and seeded into tissues before birth
and maintained by self-renewal and local proliferation (33, 34).
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FIGURE 4 | Ly6Chi monocytes are decreased in the blood in the absence of myeloid cell expression of Rora. Blood was collected from age-matched C57Bl6/J WT
and C57Bl6/J Rorasg/sg mice by submandibular bleed. (A) Ly6C expression was quantified on blood CD45+CD115+ monocytes (n = 8 WT; n = 11 Rorasg/sg ). (B)
Rora-YFP expression was quantified on Ly6Clo and Ly6Chi blood CD45+CD115+ monocytes (data is representative of 3 RoraCreRosa-YFP mice). (C) Ly6C expression
was quantified on blood monocytes isolated from Rorafl/fl and Rorafl/flLysMCre/+ mice (n = 3 Rorafl/fl; n = 4 Rorafl/flLysMCre/+ ). Data is representative of mean ± SEM.
Student’s t-test: ns, not significant, *P < 0.05.
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FIGURE 5 | RORα acts specifically on myeloid-derived macrophages, with limited effect on tissue resident cells. Bone-marrow derived macrophages (BMDM) were
isolated from age-matched WT and Rorasg/sg mice and expression of Rora determined by qRT-PCR relative to 18S (A, n = 3 WT, n = 5 Rorasg/sg ). BMDM isolated
from RoraCreRosa-YFP mice were stimulated with media-alone, LPS (100 ng/ml) or IL-4 (20 ng/ml) for 48 h and YFP+ve cells determined by flow cytometry (B, n = 3).
Peritoneal exudate cells were collected from age-matched WT and Rorasg/sg mice by peritoneal lavage and stained for flow cytometry as small peritoneal
macrophages (SPM; Live/dead−CD45+CD11b+SiglecF−F4/80+MHC class IIhi) or large peritoneal macrophages (LPM;
Live/dead−CD45+CD11b+SiglecF−F4/80hiMHC class IIlo) (C; n = 10 WT; n = 5 Rorasg/sg ). RoraCreRosa-YFP mice were injected i.p. with PBS (n = 6) or IL-4c (n = 4)
on days 0 and 2 (D,E), or thioglycollate (day 0; n = 4) with or without IL-4c (days 0 and 2; n = 4) (F). Increase in CD206+ macrophages in the peritoneal cavity of mice
following IL-4c treatment (D, gated as Live/dead−CD45+CD11b+SiglecF−F4/80+CD206+). Flow cytometry was performed on LPM (gating as above; E) or SPM
(gating as above; F) assessing Rora-YFP expression on CD206hi and CD206lo cells. Data is representative of mean ± SEM. Student’s t-test or ANOVA (E) was used
for statistical analysis: ns, not significant, *P < 0.05, **P < 0.01, ***P < 0.001.
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Assessment of peritoneal macrophage populations from Rorasg/sg
shows that while the small peritoneal macrophage (SPM; MHC
class IIhiF4/80lo) population is reduced in Rorasg/sg compared
to WT mice, the large peritoneal macrophage population (LPM;
MHC class II+F4/80hi) is comparable between the strains
(Figure 5C). This observation was also apparent in peritoneal
cells in Rorafl/flLysMCre/+ when compared to Rorafl/fl mice
(data not shown). As the SPM population is monocyte-derived,
whereas the LPM are the resident population, it indicates that
monocyte-derived macrophages are altered in the absence of
RORα with tissue-resident macrophages unaffected.
Studies herein have suggested a role for RORα in monocyte-
derived inflammatory macrophages, in the periphery and in
the adipose tissue. To further confirm these observations we
have used a method using complexed IL-4 with IL-4R (IL-
4c)-alone and in combination with thioglycollate to assess the
polarization of resident macrophages as well as recruitment and
polarization of monocyte derived macrophages (20). Injection
of IL-4c into the peritoneal cavity resulted in a significant
(P > 0.01) increase in CD206+ macrophages confirming the
efficacy of IL-4c (Figure 5D). Rora-YFP reporter mice had
modest Rora-YFP expression in the resident population, with
Rora expression not altered by polarizing the cells to an AAM
phenotype by the addition of IL-4c (Figure 5E). However,
while the injection of thioglycollate drives the recruitment
of monocyte-derived macrophages with a significant (P <
0.001) increase in Rora-YFP in the CD206lo SPM population,
thioglycollate and IL-4c in combination had reduced (P <
0.01) cells in the peritoneum (Figure 5F). While thioglycollate
or thioglycollate+IL-4c injection both increased, P < 0.01
and P < 0.001, respectively vs. PBS, Rora-YFP+ve AAM
polarized monocyte in the peritoneum, there was greater
(P < 0.01) AAM in mice received thioglycollate+IL-4c in
combination (Figure 5F). This suggests that RORα is expressed
in monocyte-derived macrophages in both CAM and AAM
polarization conditions.
DISCUSSION
Studies on RORα have identified the transcription factor as
vital in many aspects of neural function, cellular development,
immune regulation, metabolism and circadian rhythm. Herein
we demonstrate a novel role for RORα in promoting metabolic
dysfunction in a mouse model of obesity, through expression
in myeloid-derived inflammatory and metabolically active
macrophages in the adipose tissue. Further interrogation suggests
that RORα is expressed and functional predominantly in
myeloid-derived monocytes, with limited expression in tissue-
resident macrophages.
RORα has a known role in the progression of metabolic
disease, with Rorasg/sg mice refractory to weight gain and glucose
intolerance associated with feeding a high-fat diet (3). This
has been widely linked to the ability of RORα to regulate the
metabolism of glucose and lipids, indeed, cholesterol is one of the
ligands for RORα (3, 4, 35) as well as regulate genes associated
with thermogenesis (36). Indeed, there were alterations in
expression of metabolic genes in obese Rorafl/flLysMCre/+ mice
when compared to Rorafl/fl mice, particularly in genes involved in
adipose tissue browning, fatty acid oxidation and thermogenesis.
While BAT is thermogenic, with high levels of fatty acid oxidation
and production of heat, brown adipocytes can also be found in
the WAT, through induction of a thermogenic program. This
is a potential target in the treatment of obesity and metabolic
dysfunction, by promoting a process that favors the elimination
of fatty acids rather than their storage. Indeed, studies have
previously implicated RORα in the thermogenic process, with
Rorasg/sg mice expressing high levels of UCP1 in the adipose
tissue suggesting that RORα inhibits the thermogenic program
in WAT in a circadian manner (13).
Previous studies on the potential role for RORα in obesity and
metabolic dysfunction have utilized staggerer RORα deficient
mice mutant or conditional mice with ubiquitous deletion.
Herein, we show that a deletion specifically in the myeloid
cells drives a reduction in adiposity and improved metabolic
parameters. This suggests that RORα-expressing myeloid cells
are playing a vital role in these processes. Indeed, in addition
to the observed effects on gene expression in the adipose tissue,
we also see a modulation of the immune repertoire in the AT
in the absence of RORα expressing myeloid cells. An increased
percentage of Ly6Chi macrophages in the adipose tissue express
Rora-YFP, with these cells significantly decreased in the adipose
tissue of obese Rorafl/flLysMCre/+ mice. We also see a decrease
in CD9+ ATM in the absence of Rora-expressing myeloid cells,
with these cells considered an inflammatory population (31). The
reduction in the CD9+ population is interesting as these cells are
associated with lipid storage. As there was an increase in genes
associated with fatty acid oxidation in the adipose tissue of obese
Rorafl/flLysMCre/+ (Figure 2D), it support that RORαmay play a
role suppressing these genes in the ATM as well as the adipocytes.
Resident and circulating monocytes are derived from different
origins, with resident macrophages, including peritoneal resident
macrophages, derived from an embryonic precursor and
maintained by self-proliferation and renewal (33, 34, 37).
Additionally, circulating monocytes can infiltrate the tissue,
where they differentiate to an inflammatory or anti-inflammatory
phenotype dependent upon the local cytokine and mediator
milieu they are exposed to (38). Thus, resident and inflammatory
macrophages are both developmentally and functionally distinct
populations (39). Interestingly the Ly6Chi population of ATM
are thought to be recently recruited into the adipose tissue
from the blood, retaining Ly6C expression, approximately 25%
of these cells express Rora-YFP. Using the peritoneal cavity as
a source of resident macrophages, the number and phenotype
of this population is comparable in the absence of functional
RORα, however the SPM, a monocyte-derived population, are
significantly decreased in number. This suggests that during the
embryonic stage where the resident cells are initially seeded,
there is no apparent role for RORα in the generation of resident
peritoneal macrophages, however, RORα does appear to impact
on the recruitment of infiltrating monocytes into the peritoneal
cavity. Indeed, we have previously noticed circulating levels of
CCL2, a chemokine well-defined as a recruitment signal for
monocytes (40), are significantly decreased in Rorasg/sg mice.
These studies suggest a potential differential role for RORα
in resident and infiltrating macrophages, however, we have
only addressed peritoneal macrophages in this study, other
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tissue macrophages would need to be explored to strengthen
this hypothesis.
Our data support a multi-faceted and cell specific role
for RORα in immune regulation beyond an ability to
inhibit inflammatory signaling. While RORα may promote
intercellular anti-inflammatory signaling pathways, its
ability to shape the immune cell repertoire and promote
recruitment and activation of pro-inflammatory macrophages
demonstrates that RORα also promotes inflammation. These
data demonstrate new functions for RORα in macrophage
activation and differentiation that is relevant to the
associations of RORA with inflammatory and metabolic
disease in man.
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Supplementary Figure 1 | Fluorescence-activated cell sorting confirms Rora
expression in YFP+ve cells. (A) Splenocytes were prepared from
RoraCreRosa-YFP mice and stained with CD45. The gating strategy isolates
doublets and dead cells. The resultant CD45+ cells are sorted based on YFP
expression, with a YFP-ve and YFP+ve population collected. The purity of the
YFP+ve population is ∼90%. (B) RNA was isolated from the sorted YFP-ve and
YFP+ve populations and expression of Rora quantified relative to 18S. Data is
representative of 3 independent sorts.
Supplementary Figure 2 | Macrophages are the predominate Rora-YFP
expressing cell in the adipose tissue. RoraCreRosa-YFP mice were fed a high-fat
diet for 12 weeks and flow cytometry performed on epididymal white adipose
tissue. (A) Cells were gated as Live/dead−CD45+Rora-YFP+ and the cells within
the Rora-YFP gate assessed. The percentage of CD4+ T cells
(Rora-YFP+CD45+CD4+), ILC2(Rora-YFP+CD45+CD4−Lineage−Sca-1+
IL-7Ra+), eosinophils (Rora-YFP+CD45+CD4−CD11b+SiglecF+ ), and
macrophages (Rora-YFP+CD45+CD4−CD11b+SiglecF−F4/80+) is expressed as
a proportion of Rora-YFP+CD45+) cells. (B) Rora-YFP expression was assessed
in Live/dead−CD45− cells in the stromal vascular fraction of the E-WAT of
RoraCreRosa-YFP reporter mice and control RoraCre mice. Data is representative
of 3 mice.
Supplementary Figure 3 | Rorafl/fl IL-7RaCre mice display exacerbated weight
gain when fed a high-fat diet. Groups of Rorafl/fl and Rorafl/fl IL-7RaCre/+ mice
were fed a high-fat diet (HFD; 60% fat) for 14 weeks and weight monitored weekly,
percentage weight gain was calculated from the starting weight of each animal
(A). E-WAT weight was determined after 14 weeks on HFD (B). All data is
representative of mean ± SEM (n = 3 Rorafl/fl; n = 7 Rorafl/fl IL-7RaCre/+ mice).
Student’s t-test: ∗P < 0.05.
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